Built-in flexibility to meet your needs

• Designed for both low- and high-volume testing on the PROCLEIX^® System.
• Choose Individual Donor Testing (IDT) or select a pool size of 4, 8 or 16 with PROCLEIX^® CPT Pooling Software.

Optimized for maximum efficiency

• Throughput of up to 3,008 results in pools of 16 or up to 188 IDT results per operator.
• Results available in 5 to 6 hours.

Unsurpassed performance¹

• 97% detection at 10 copies/mL in Analytical Sensitivity studies
• Clinical Specificity: ~ 99.9%
• Detects both Lineage 1 and 2 viruses with similar sensitivity

PROCLEIX is a trademark of Novartis Vaccines and Diagnostics, Inc.
Developed by Gen-Probe in collaboration with Novartis Vaccines and Diagnostics, Inc. Manufactured by Gen-Probe Incorporated. Distributed by Novartis Vaccines and Diagnostics, Inc.

References

1. PROCLEIX^® WNV Assay package insert

Download the Intended Use document
(1.32 MB)